Recombinant Human PLA2G2A Protein，His

PLA2G2A, or Secretory Phospholipase A2 Group IIA, is an important enzyme implicated in various physiological and pathological processes, including inflammation, host defense, and lipid metabolism. As a secreted enzyme, PLA2G2A plays a crucial role in the hydrolysis of phospholipids, leading to the release of lysophospholipids and free fatty acids, which can modulate cellular signaling and immune responses. Research has demonstrated that PLA2G2A is involved in the inflammatory response, making it a potential biomarker and therapeutic target for inflammatory diseases, such as rheumatoid arthritis and atherosclerosis. Furthermore, studies have indicated that PLA2G2A exhibits antimicrobial properties, suggesting its role in innate immunity against bacterial infections. The recombinant expression of PLA2G2A has gained attention for its potential applications in drug development and therapeutic strategies. By producing recombinant PLA2G2A in suitable expression systems, researchers can obtain large quantities of the enzyme for biochemical studies, structural characterization, and high-throughput screening of small molecules that may modulate its activity. Understanding the structure-function relationship of PLA2G2A through recombinant technology can provide insights into its mechanism of action and facilitate the development of novel inhibitors or modulators. Given the enzyme's significance in health and disease, the study of PLA2G2A as a recombinant protein is a promising area of research that may lead to advancements in therapeutic interventions and diagnostic tools for various inflammatory and infectious diseases.